Population Health Sciences, University of Bristol, Bristol, UK
Population Health Sciences, University of Bristol, Bristol, UK.
BMJ Open. 2022 Sep 1;12(9):e059228. doi: 10.1136/bmjopen-2021-059228.
To review guidance, included in written local UK National Health Service (NHS) organisation policies, on information provision and consent for the introduction of new invasive procedures- including surgeries, and devices (IPs/Ds).
A qualitative documentary analysis of data on patient information provision and consent extracted from policies for the introduction of IP/Ds from NHS organisations in England and Wales.
NHS trusts in England and health boards in Wales, UK.
Between December 2017 and July 2018, 150 acute trusts in England and 7 health boards in Wales were approached for their policies for the introduction of new IP/Ds. In total, 123 policies were received, 11 did not fit the inclusion criteria and a further policy was included from a trust website resulting in 113 policies included for review.
From the 113 policies, 22 did not include any statements on informed consent/information provision or lacked guidance on the information to be provided to patients and were hence excluded. Consequently, 91 written local NHS policies were included in the final dataset. Within the guidance obtained, variation existed on disclosure of the procedure's novelty, potential risks, benefits, uncertainties, alternative treatments and surgeon's experience. Few policies stated that clinicians should discuss the existing evidence associated with a procedure. Additionally, while the majority of policies referred to patients needing written information, this was often not mandated and few policies specified the information to be included.
Nearly a fifth of all the policies lacked guidance on information to be provided to patients. There was variability in the policy documents regarding what patients should be told about innovative procedures. Further research is needed to ascertain the information and level of detail appropriate for patients when considering innovative procedures. A core information set including patients' and clinicians' views is required to address variability around information provision/consent for innovative procedures.
审查英国国家医疗服务体系(NHS)书面组织政策中有关新介入性程序(包括手术和器械)引入时的信息提供和同意的指导意见。
对英格兰 NHS 组织中引入 IP/Ds 的政策中提取的关于患者信息提供和同意的定性文件分析。
英格兰的 NHS 信托和威尔士的卫生委员会。
2017 年 12 月至 2018 年 7 月,向英格兰的 150 家急症信托机构和威尔士的 7 家卫生委员会提出了其引入新 IP/Ds 的政策。共收到 123 项政策,其中 11 项不符合纳入标准,另有 1 项政策来自信托网站,因此纳入 113 项政策进行审查。
在 113 项政策中,有 22 项没有任何关于知情同意/信息提供的陈述,或者缺乏向患者提供的信息指南,因此被排除在外。因此,最终数据集包括 91 份书面的当地 NHS 政策。在获得的指导意见中,披露程序的新颖性、潜在风险、益处、不确定性、替代治疗方法和外科医生的经验存在差异。很少有政策规定临床医生应讨论与手术相关的现有证据。此外,虽然大多数政策都提到患者需要书面信息,但这通常不是强制性的,而且很少有政策具体规定应包括的信息。
近五分之一的政策缺乏向患者提供信息的指导。在关于应告知患者有关创新程序的内容方面,政策文件存在差异。需要进一步研究,以确定在考虑创新程序时患者需要的信息和详细程度。需要一套核心信息,包括患者和临床医生的意见,以解决创新程序信息提供/同意方面的差异。